Cervical cancer prevention in the 21st century: Cost is not the only issue

American Journal of Public Health

Volumn 101, Issue 9, 2011, Pages 1549-1555

  Maine, Deborah ^a,b   Hurlburt, Sarah ^a   Greeson, Dana ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; DEVELOPING COUNTRY; EARLY DIAGNOSIS; ECONOMICS; FEMALE; HUMAN; METHODOLOGY; PAPILLOMAVIRUS INFECTION; TIME; UTERINE CERVIX TUMOR;

DEVELOPING COUNTRIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; TIME FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 80052007539     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2011.300204     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. (Pubitemid 40372904)
2. Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities. PLoS Med. 2008;5(6): e132.
3. World Health Organization, United Nations Population Fund. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries. 2006. Available at: http://whqlibdoc.who.int/hq/2006/WHO-RHR-06.11-eng.pdf. Accessed May 16, 2011.
4. Centers for Disease Control and Prevention. Genital HPV infection-fact sheet. November 24, 2009. Available at: http://www.cdc.gov/std/hpv/stdfact-hpv. htm. Accessed May 16, 2011.
5. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385-1394.
6. Sankaranarayanan R. ACCP evidence base: implications for policy and practice. World Health Organization, International Agency for Research on Cancer. 2006. Powerpoint presentation. Available at: http://www.alliance-cxca. org. Accessed May 16, 2011.
7. Perkins R, Langrish S, Stern L, Figueroa J, Simon C. Comparison of visual inspection and Papanicolaou (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned? Trop Med Int Health. 2007;12(9): 1018-1025. (Pubitemid 47414940)
8. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000;132(10): 810-819. (Pubitemid 30317797)
9. Sankaranarayanan R, Wesley R, Thara S, et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003;106(3):404-408. (Pubitemid 36870404)
10. Cervical Cancer Prevention Initiatives at PATH: Two Decades of Progress Toward a World Free of HPV-Related Cancers. Seattle, WA: Program for Appropriate Technology in Health (PATH); 2008. Available at: http://www.rho.org/files/PATH- cxca-rep-to-world.pdf. Accessed May 16, 2011.
11. Patient Education Pamphlet-Gynecologic Problems (AP163): Cancer of the Cervix. Washington, DC: American College of Obstetrics and Gynecologists; 2004.
12. Castro W, Gage J, Gaffikin L, et al. Effectiveness, Safety, and Acceptability of Cryotherapy: A Systematic Literature Review. Seattle, WA: Alliance for Cervical Cancer Prevention; 2003.
13. Merck & Co. Form 10-K: annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2007. February 28, 2008. Available at: http://www.merck.com/finance/proxy/2007- form-10-k.pdf. Accessed May 16, 2011.
14. Goldie S, Gaffikin L, Goldhaber-Fiebert J, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20): 2158-2168. (Pubitemid 41653107)
15. What You Need to Know About Cervical Cancer. Bethesda, MD: National Cancer Institute, National Institutes of Health; 2008.
16. Sirovich B, Welch G. The frequency of Pap smear screening in the United States. J Gen Intern Med. 2004;19(3): 243-250. (Pubitemid 38388934)
17. National Institutes of Health (NIH). Cervical cancer: NIH Consensus Development Conference Statement, April 1-3, 1996. Available at: http://consensus.nih.gov/1996/1996CervicalCancer102html.htm. Accessed May 16th, 2011.
18. Russell L. Educated Guesses: Making Policy About Medical Screening Tests. Berkeley: University of California Press; 1994.
19. Agosti J, Goldie S. Introducing HPV vaccine in developing countries-key challenges and issues. N Engl J Med. 2007;356(19):1908-1910. (Pubitemid 46740300)
20. Kim J, Goldie S. Health and economic implications of HPV vaccination in the United States. N Engl J Med. 2008;359(8): 821-832.
21. World Health Organization. Core health indicators. Available at: http://www.who.int/whosis/database/core/core-select-process.cfm. Accessed May 27, 2010.
22. American Cancer Society. Detailed guide: cervical cancer: can cervical cancer be prevented? Available at: http://www.cancer.org/cancer/cervicalcancer/ detailedguide/cervical-cancer-prevention. Accessed May 16, 2011.